What is Semaglutide in laboratory research?
It is a GLP-1 receptor agonist used to investigate incretin signalling and peptide-receptor pharmacology.
Research materialResearch use only
Documentation
Live catalogue
Technical Specifications
A modified GLP-1 analogue peptide. Current strengths, pricing, stock, images, and purchase controls remain live Commerce data.
Back to catalogue
Research material
Semaglutide
Semaglutide is a synthetic GLP-1 receptor agonist peptide studied in incretin biology and metabolic signalling research. It is an analogue of glucagon-like peptide-1, an endogenous peptide hormone involved in nutrient-responsive communication across pancreatic, gastrointestinal, and central systems. Structural modification is designed to alter its pharmacokinetic profile relative to native GLP-1, making it useful for experimental comparisons involving receptor activation over time. Researchers examine semaglutide in receptor assays, cell systems, animal models, and clinical literature; each evidence layer answers different questions. It is supplied as a research material only and is not intended for human or veterinary use.
Research highlights
- GLP-1 receptor pharmacology; incretin signalling; endocrine communication; beta-cell biology; peptide-analogue structure–function studies.
- The literature encompasses biochemical, cellular, animal, and clinical research. This page summarizes scientific context without therapeutic claims.
Select size / quantity
Select Volume
Live CAD price
$59.99
Selected size
Semaglutide 10MGCurrently sold out — available for pre-order
Pre-orders are accepted. Shipment will occur when stock is replenished.
Quantity
1
For research purposes only. Not for human or veterinary use.
Free shipping on orders over $250 CAD
Multi-unit savings: 3 units — 10% off · 5 units — 15% off · 10 units — 20% off. Promotional savings are subject to confirmation at checkout.
Technical Specifications
A modified GLP-1 analogue peptide. Current strengths, pricing, stock, images, and purchase controls remain live Commerce data.
Research use only
Materials are intended strictly for laboratory and analytical research.
Contact research supportMechanism & Research Pathways
GLP-1R is a class B GPCR that typically signals through Gs and cAMP-associated pathways. Semaglutide research examines receptor activation, downstream second-messenger responses, beta-cell signalling, neuronal circuits, and ligand structure–function relationships. Depending on the system, investigators may also evaluate receptor internalization, desensitization, and biased signalling. Experimental findings concerning integrated metabolism or behaviour are model-specific and should not be converted into individual outcomes. The appropriate interpretation depends on experimental design, comparator ligands, and measured endpoints.
Research Context
The literature encompasses biochemical, cellular, animal, and clinical research. This page summarizes scientific context without therapeutic claims.
Frequently Asked Research Questions
What is its main research target?
The primary target is the glucagon-like peptide-1 receptor, GLP-1R.
Why compare it with native GLP-1?
Comparative studies can examine how peptide modifications influence receptor signalling and experimental time-course behaviour.